Rabbit monoclonal [H26-10] Anti-Human IgG1 H&L (Biotin)
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Recombinant secondary antibody suitable for IHC-P, ELISA. Cited in 6 publications.
View Alternative Names
Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Rabbit monoclonal [H26-10] Anti-Human IgG1 H&L (Biotin) (AB201485)
IHC image of Human IgG1 H & L staining in a section of formalin-fixed paraffin-embedded normal human tonsil*, performed on a Leica BondTM. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins, before blocking of endogenous biotin using ab64212. The section was then incubated with ab201485, 1/500 dilution, for 15 mins at room temperature and detected using an HRP conjugated ABC system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset negative control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Rabbit monoclonal [H26-10] Anti-Human IgG1 H&L (Biotin) (AB201485)
Negative IHC image of Human IgG1 H & L staining in a section of formalin-fixed paraffin-embedded normal human cerebral cortex, performed on a Leica BondTM. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins, before blocking of endogenous biotin using ab64212. The section was then incubated with ab201485, 1/500 dilution, for 15 mins at room temperature and detected using an HRP conjugated ABC system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset negative control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- ELISA
Lab
ELISA - Rabbit monoclonal [H26-10] Anti-Human IgG1 H&L (Biotin) (AB201485)
ab201485 was tested using a sandwich ELISA approach. The wells were coated with ab200699 at 5μg/ml at 50μl/well overnight at 4°C, followed by a 5% BSA blocking step for 2h RT. Human IgG1 (ab90283) was then added starting at 100 μg/ml and plasma/serum at 1 : 50 and gradually diluted 1 : 4, 50μl/well for 2h. ab201485 was then added at 1 : 10,000 dilution, 50μl/well for 2h. A HRP-streptavidin (ab7403) was used at 1 : 10,000 dilution for 1h.
Related conjugates and formulations (4)
-
665 Alexa Fluor® 647
Rabbit monoclonal [H26-10] Anti-Human IgG1 H&L (Alexa Fluor® 647)
-
519 Alexa Fluor® 488
Rabbit monoclonal [H26-10] Anti-Human IgG1 H&L (Alexa Fluor® 488)
-
Rabbit monoclonal [H26-10] Anti-Human IgG1 H&L
-
Rabbit monoclonal [H26-10] Anti-Human IgG1 H&L - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 16:1654655 PubMed41050654
2025
Applications
Unspecified application
Species
Unspecified reactive species
International urology and nephrology : PubMed38381285
2024
Applications
Unspecified application
Species
Unspecified reactive species
Disease markers 2021:5511041 PubMed34354775
2021
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 11:2637-2653 PubMed34249419
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:454 PubMed33747188
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 20:11 PubMed32934676
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com